IGC Pharma, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2017
Total Assets: $11.3M
Liabilities Breakdown FY2017
Total Liabilities: $3.9M
Asset Breakdown
Total Assets: $11.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $538.0K | 4.8% |
| Accounts Receivable | $752.9K | 6.7% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $953.9K | 8.5% |
| Goodwill | $198.2K | 1.8% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $8.8M | 78.4% |
Liabilities Breakdown
Total Liabilities: $3.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $416.5K | 10.6% |
| Long-Term Debt | $452.1K | 11.5% |
| Other Liabilities | $3.1M | 77.9% |